Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by APOA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. Additionally we are shipping Apolipoprotein A Kits (12) and Apolipoprotein A Proteins (3) and many more products for this protein.
Showing 10 out of 51 products:
Human Monoclonal APOA Primary Antibody for ICC, IHC - ABIN969533
Nicholls, Tang, Scoffone, Brennan, Hartiala, Allayee, Hazen: Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. in Journal of lipid research 2010
Show all 2 references for ABIN969533
Human Monoclonal APOA Primary Antibody for IHC, ELISA - ABIN969261
Ranga, Kalra, Tandon, Gambhir, Mehrotra: Effect of aspirin on lipoprotein(a) in patients with ischemic stroke. in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2007
Show all 2 references for ABIN969261
Elevated Lp(a) may identify female patients with increased cardiovascular disease.
Among patients with acute coronay syndrome, raised Lp(a) levels are associated with an increased atherosclerotic burden and it identifies a subset of patients with features of high risk coronary atherosclerosis.
diabetic retinopathy was independently associated with the serum Lp(a) level in patients with type 2 diabetes
tests of association using logistic regression assuming an additive genetic model revealed no significant associations (p<0.05) for any of the five LPA variants previously associated with Lp(a) levels in African Americans
These data demonstrate that serum Lp(a) is elevated in patients with FH caused by PCSK9 (show PCSK9 Antibodies) gain-of-function mutations to the same level as that in FH caused by LDLR (show LDLR Antibodies) mutations.
study provides evidence that ancestry-specific causal risk variant(s) resides in or near LPA and that most of the observed associations outside this narrower region are spurious associations.
Data suggest plasma levels of PCSK9 (proprotein convertase subtilisin/kexin type 9 (show PCSK9 Antibodies)) and lipoprotein(a) are significantly up-regulated in patients with type 2 diabetes as compared to control subject; study was conducted in Tunisia.
oxLp(a) induced autophagy via LKB1 (show STK11 Antibodies)-AMPK (show PRKAA1 Antibodies)-mTOR (show FRAP1 Antibodies) and PAPR-1-LKB1 (show STK11 Antibodies)-AMPK (show PRKAA1 Antibodies)-mTOR (show FRAP1 Antibodies) pathways, which are dependent on ROS (show ROS1 Antibodies) generation
LPA rs3798220 does not appear to be associated with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians
Elevated Lp(a) is an independent risk factor for ischemic stroke and may be especially relevant for young stroke patients [meta-analysis]
The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence.
antiangiogenic AK38 protein